Facebook Linkedin RSS Twitter Youtube
Home 2023

Teva

StockWatch: Novo Nordisk Shares Soar as Ozempic Aces Phase III CKD Trial
Drug Discovery

StockWatch: Novo Nordisk Shares Soar as Ozempic Aces Phase III CKD Trial

Alex Philippidis -
0
venBio Writes New Chapter with $550M Fourth Fund
Drug Discovery

venBio Writes New Chapter with $550M Fourth Fund

Alex Philippidis -
0
Insilico and Teva Collaborate on Bioproduction
Bioprocessing

Insilico and Teva Collaborate on Bioproduction

John Sterling -
0
Teva Wins FDA Approval for Digital Inhaler Combining Powder with Sensors, App
Drug Discovery

Teva Wins FDA Approval for Digital Inhaler Combining Powder with Sensors, App

Alex Philippidis -
0
Teva Halts Phase III Trial of Fremanezumab in Chronic Cluster Headaches
Drug Discovery

Teva Halts Phase III Trial of Fremanezumab in Chronic Cluster Headaches

GEN Staff Writer -
0
Teva Axing 14,000 Positions, Shutting Facilities Worldwide
Drug Discovery

Teva Axing 14,000 Positions, Shutting Facilities Worldwide

GEN Staff Writer -
0
Supreme Court’s Sandoz–Amgen Decision Boosts Biosimilars
Drug Discovery

Supreme Court’s Sandoz–Amgen Decision Boosts Biosimilars

GEN Staff Writer -
0
Insights
News

Insights

GEN Staff Writer -
0
Teva Receives FDA Warning Letter on China API Plant
Drug Discovery

Teva Receives FDA Warning Letter on China API Plant

GEN Staff Writer -
0
FDA Approves Teva’s AUSTEDO for Treating Huntington’s Disease
Drug Discovery

FDA Approves Teva’s AUSTEDO for Treating Huntington’s Disease

GEN Staff Writer -
0
123...11Page 1 of 11
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.